Total testosterone (nmol/l) |
20.9 (7.1) |
Bioavailable testosterone (nmol/l) |
0.34 (0.08) |
Sex hormone binding globulin (nmol/l) |
55.3 (23.6) |
Age (years) |
45 (6) |
Randomization arm (n,%) |
|
Conventional |
259 (51%) |
Intensive |
249 (49%) |
Primary cohort (n,%) |
257 (51%) |
Current smoking (n,%) |
59 (12%) |
Current alcohol use (n,%) |
260 (51%) |
Body mass index (n,%) |
|
< 25 kg/m2
|
173 (34%) |
25-29.9 kg/m2
|
288 (57%) |
≥30 kg/m2
|
47 (9%) |
Time-weighted body mass index (kg/m2) |
26.1 (2.8) |
Time-weighted insulin dose (units/kg/day) |
0.7 (0.2) |
Time-weighted DCCT/EDIC HbA1c (mmol/mol) |
64 (11) |
Anti-hypertensive medication use (%) |
279 (55%) |
Time-weighted systolic blood pressure (mm Hg) |
120 (8) |
Time-weighted low-density lipoprotein cholesterol (mg/dl) |
114 (23) |
Time-weighted high-density lipoprotein cholesterol (mg/dl) |
49 (11) |
History of albumin excretion ratio ≥ 300 mg/24 hours (n, %) |
49 (10%) |
Left ventricular mass index (g/m2) |
76.5 (12.3) |
End-diastolic volume (ml/m2) |
73.3 (12.6) |
End-systolic volume (ml/m2) |
29.2 (7.8) |
Stroke volume index (ml/m2) |
44.1 (8.0) |
Ejection fraction (%) |
60.3 (6.3) |
Cardiac output (L• min-1•m-2) |
3.1 (0.6) |
Left ventricular mass/end-diastolic volume (mg/ml) |
1.1 (0.2) |